Beta-blockers in Clinical Practice PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Beta-blockers in Clinical Practice PDF full book. Access full book title Beta-blockers in Clinical Practice by J. M. Cruickshank. Download full books in PDF and EPUB format.
Author: J. M. Cruickshank
Publisher: W.B. Saunders Company
ISBN:
Category : Medical
Languages : en
Pages : 1224
Get Book Here
Book Description
Discusses this important class of drugs, which are the subject of considerable on-going research. Includes an expanded pharmacopoeia, new chapters on physiology and health economics, and major changes in the chapters on the prevention of heart attacks and the athermatous process.
Author: J. M. Cruickshank
Publisher: W.B. Saunders Company
ISBN:
Category : Medical
Languages : en
Pages : 1224
Get Book Here
Book Description
Discusses this important class of drugs, which are the subject of considerable on-going research. Includes an expanded pharmacopoeia, new chapters on physiology and health economics, and major changes in the chapters on the prevention of heart attacks and the athermatous process.
Author: J.M. Cruickshank
Publisher: Churchill Livingstone
ISBN: 9780443039881
Category :
Languages : en
Pages :
Get Book Here
Book Description
Author: Anton N Sidawy
Publisher: Elsevier Health Sciences
ISBN: 0323581307
Category : Medical
Languages : en
Pages : 2838
Get Book Here
Book Description
Through nine outstanding editions, Rutherford's Vascular Surgery and Endovascular Therapy has been the gold standard text in this fast-changing, complex field. Published in association with the Society for Vascular Surgery, this state-of-the-art reference by Drs. Anton N. Sidawy and Bruce A. Perler is a must-have for vascular surgeons, interventionalists, vascular medicine specialists, and trainees, as well as general surgeons, interventional radiologists, and cardiologists that depend upon "Rutherford’s" in their practice. It offers authoritative guidance from the most respected and innovative global thought leaders and clinical and basic science experts in the diagnosis and treatment of circulatory disease. Incorporates medical, endovascular, and surgical treatment, as well as diagnostic techniques, decision making, and fundamental vascular biology. Features all vascular imaging techniques, offering a non-invasive evaluation of both the morphology and hemodynamics of the vascular system. Provides unparalleled insight from multidisciplinary leaders worldwide, who share their expertise on the most appropriate contemporary and future treatment of circulatory disease. Employs a full-color layout and images so you can view clinical and physical findings and operative techniques more vividly. Includes 40 new chapters incorporating a shorter, more focused format with a summary for each chapter that provides a quick access to key information – ideal for consultation situations as well as daily practice. Some of these chapters are organized in new sections dedicated to open operative exposure and vessel dissection techniques, diabetic foot, Pediatric Vascular Disease, and practice management issues; areas in the specialty that clinicians frequently face but seldom detailed in other vascular texts nor in earlier Rutherford editions. Covers hot topics such as endovascular therapy of aortic arch and thoracoabdominal aortic aneurysm disease, including the evolving management of aortic dissections. Expert ConsultTM eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, and references from the book on a variety of devices.
Author: J. M. Cruickshank
Publisher: PMPH-USA
ISBN: 1607951088
Category : Adrenergic beta blockers
Languages : en
Pages : 286
Get Book Here
Book Description
The book provides a concise much-needed update of beta-blockers use cardiovascular area (particularly hypertension and heart failure). It will uncover the clinical inaccuracies of how the UK NICE Committee have "got it wrong" in their recent pronouncements on BBs and hypertension. Beta-blockers (BBs) are a large and important family of therapeutic agents with primary use is in cardiovascular medicine. The therapeutic areas that BB covers include: Ischemic Heart Disease, Hypertension, Heart Failure and Arrhythmias. Explanation of the role of BBs in the treatment of hypertension and why the UK Health Authority (The NICE Committee) have "got it wrong" A current update of the vital role of beta-blockers in the treatment of heart failure, and why some beta-blockers are "ineffective" Provides a total and current update of the role of beta-blockers in cardiovascular medicine.
Author: Yirga Legesse Niriayo
Publisher:
ISBN: 9781022898820
Category : Medical
Languages : en
Pages : 0
Get Book Here
Book Description
Beta-Blockers in Clinical Practice: Insights from Contemporary Research is a comprehensive compilation of scientific journal articles that delve into the diverse applications and implications of beta-blockers in medical treatments. This anthology investigates the role of beta-blockers across a spectrum of conditions including chronic heart failure, hypertension in older adults, and their emerging significance in oncology. The book highlights an Ethiopian study that explores the optimization of beta-blocker dosages in chronic heart failure patients, uncovering significant gaps in clinical practice adherence despite established guidelines. A systematic review examines the risk-benefit balance of beta-blockers for hypertension treatment in older adults, pushing clinicians to reassess traditional practices. Noteworthy articles discuss the protective association of beta-blockers in melanoma and metastatic colorectal cancer patients, spurring new interdisciplinary discussions between oncologists and cardiologists. Additionally, articles address the pharmacological safety of beta-blockers in patients with respiratory conditions such as COPD and asthma, and their tailored use in specific scenarios like preoperative care and rheumatoid arthritis post-myocardial infarction. Through systematic reviews, meta-analyses, and observational studies, this collection encourages medical professionals to challenge conventional wisdom and embrace a continuously evolving approach to patient care. By presenting rigorous scientific inquiry and nuanced explorations, this book serves as a valuable resource illuminating the multifaceted effects of beta-blockers in contemporary clinical practice. Quality Research Publishing is dedicated to making knowledge more accessible to the general public by curating a topical compilation of the latest research on various subjects and providing plain language summaries. Each of the articles in this book is available individually and digitally without cost. However, we believe it is important for the contextualizing and sharing of educational and scientific work to curate this research in a way that is understandable and helpful to the average person seeking deeper knowledge of a particular subject. The research articles compiled for this book were published under a permissive Creative Commons license, are in the public domain, or have no copyright restrictions, permitting their use in this book. If you have questions about the licensing of any article, please visit qualityresearchpublishing.com.
Author: Paul A. Heidenreich
Publisher: Agency for Healthcare Research & Quality
ISBN:
Category : Medical
Languages : en
Pages : 140
Get Book Here
Book Description
Author: Neil Kaplowitz
Publisher: CRC Press
ISBN: 0203909127
Category : Medical
Languages : en
Pages : 790
Get Book Here
Book Description
Featuring more than 4100 references, Drug-Induced Liver Disease will be an invaluable reference for gastroenterologists, hepatologists, family physicians, internists, pathologists, pharmacists, pharmacologists, and clinical toxicologists, and graduate and medical school students in these disciplines.
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309282810
Category : Medical
Languages : en
Pages : 437
Get Book Here
Book Description
America's health care system has become too complex and costly to continue business as usual. Best Care at Lower Cost explains that inefficiencies, an overwhelming amount of data, and other economic and quality barriers hinder progress in improving health and threaten the nation's economic stability and global competitiveness. According to this report, the knowledge and tools exist to put the health system on the right course to achieve continuous improvement and better quality care at a lower cost. The costs of the system's current inefficiency underscore the urgent need for a systemwide transformation. About 30 percent of health spending in 2009-roughly $750 billion-was wasted on unnecessary services, excessive administrative costs, fraud, and other problems. Moreover, inefficiencies cause needless suffering. By one estimate, roughly 75,000 deaths might have been averted in 2005 if every state had delivered care at the quality level of the best performing state. This report states that the way health care providers currently train, practice, and learn new information cannot keep pace with the flood of research discoveries and technological advances. About 75 million Americans have more than one chronic condition, requiring coordination among multiple specialists and therapies, which can increase the potential for miscommunication, misdiagnosis, potentially conflicting interventions, and dangerous drug interactions. Best Care at Lower Cost emphasizes that a better use of data is a critical element of a continuously improving health system, such as mobile technologies and electronic health records that offer significant potential to capture and share health data better. In order for this to occur, the National Coordinator for Health Information Technology, IT developers, and standard-setting organizations should ensure that these systems are robust and interoperable. Clinicians and care organizations should fully adopt these technologies, and patients should be encouraged to use tools, such as personal health information portals, to actively engage in their care. This book is a call to action that will guide health care providers; administrators; caregivers; policy makers; health professionals; federal, state, and local government agencies; private and public health organizations; and educational institutions.
Author: Stephan Gielen
Publisher: European Society of Cardiology
ISBN: 0199656657
Category : Medical
Languages : en
Pages : 369
Get Book Here
Book Description
"EACPR, European Association for Cardiovascular Prevention and Rehabilitation -- European Society of Cardiology."
Author: Hyman J. Zimmerman
Publisher: Lippincott Williams & Wilkins
ISBN: 9780781719520
Category : Medical
Languages : en
Pages : 848
Get Book Here
Book Description
Written by the foremost authority in the field, this volume is a comprehensive review of the multifaceted phenomenon of hepatotoxicity. Dr. Zimmerman examines the interface between chemicals and the liver; the latest research in experimental hepatotoxicology; the hepatotoxic risks of household, industrial, and environmental chemicals; and the adverse effects of drugs on the liver. This thoroughly revised, updated Second Edition features a greatly expanded section on the wide variety of drugs that can cause liver injury. For quick reference, an appendix lists these medications and their associated hepatic injuries. Also included are in-depth discussions of drug metabolism and factors affecting susceptibility to liver injury.
